|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-10
|
|
pubmed:abstractText |
Chemotherapy-induced nausea and vomiting (CINV) is one of the most distressing side effects of moderately or highly emetogenic chemotherapy. Diphenhydramine, lorazepam, and dexamethasone have been used individually to treat CINV. The objective of this study was to evaluate the safety and potential efficacy of those drugs administered via a patient controlled pump (BAD pump) to control CINV.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiemetics,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Diphenhydramine,
http://linkedlifedata.com/resource/pubmed/chemical/Granisetron,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Lorazepam,
http://linkedlifedata.com/resource/pubmed/chemical/Ondansetron,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolizines,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT3 Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/dolasetron mesylate
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1545-5009
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2006 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
330-2
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16304666-Adolescent,
pubmed-meshheading:16304666-Antiemetics,
pubmed-meshheading:16304666-Antineoplastic Agents,
pubmed-meshheading:16304666-Child,
pubmed-meshheading:16304666-Child, Preschool,
pubmed-meshheading:16304666-Confusion,
pubmed-meshheading:16304666-Dexamethasone,
pubmed-meshheading:16304666-Diphenhydramine,
pubmed-meshheading:16304666-Drug Therapy, Combination,
pubmed-meshheading:16304666-Female,
pubmed-meshheading:16304666-Granisetron,
pubmed-meshheading:16304666-Humans,
pubmed-meshheading:16304666-Indoles,
pubmed-meshheading:16304666-Infusion Pumps,
pubmed-meshheading:16304666-Infusions, Intravenous,
pubmed-meshheading:16304666-Length of Stay,
pubmed-meshheading:16304666-Lorazepam,
pubmed-meshheading:16304666-Male,
pubmed-meshheading:16304666-Mood Disorders,
pubmed-meshheading:16304666-Ondansetron,
pubmed-meshheading:16304666-Patient Acceptance of Health Care,
pubmed-meshheading:16304666-Quinolizines,
pubmed-meshheading:16304666-Retrospective Studies,
pubmed-meshheading:16304666-Self Administration,
pubmed-meshheading:16304666-Serotonin 5-HT3 Receptor Antagonists,
pubmed-meshheading:16304666-Serotonin Antagonists,
pubmed-meshheading:16304666-Treatment Outcome,
pubmed-meshheading:16304666-Vomiting
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
|
|
pubmed:affiliation |
Pediatric Hematology/Oncology, Vanderbilt University, Nashville, Tennessee, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
